Week 1 HW: First Project Idea

Biomanufacturing of Recombinant Taq DNA Polymerase in Africa

Recombinant Taq DNA polymerase is an important part of molecular research. It is, however, expensive due to high import costs, foreign exchange volatility, and cold chain storage requirements. As a result, many students and researchers in Africa are not encouraged to pursue molecular research. This impedes scientific research progress and impacts the quality of research many scientists can fund and undertake.

The Living System of Choice

E. coli is the manufacturing chassis that would produce Taq DNA polymerase. This enzyme can be isolated from Thermus aquaticus, a thermophilic bacterium found in naturally hot environments like springs and geysers. It is, however, not used for large-scale production because it grows very slowly and produces the enzyme in small amounts. The Taq gene is isolated from Thermus aquaticus and placed into a circular DNA (plasmid). The engineered plasmid is then introduced into E.coli strains in the laboratory, which take up the foreign DNA. Expression of the gene is induced by adding a trigger to the growth medium containing E.coli.

Introducing Automation

I would automate the E.coli upstream fermentation and cultivation process using, for example, an automated bioreactor and fermenter, automated feed systems, and autoinduction systems. This would ensure precise growth under controlled physical conditions like temperature and pH.

Manufacturing Estimate

Assuming there are 1,000 molecular biology laboratories, with each laboratory carrying out approximately 1,000 PCR reactions per month.

1,000 laboratories × 1,000 PCR reactions/laboratory/month

= 1,000,000 PCR reactions/month

(This is a planning assumption for the purpose of the calculation rather than an estimate of the actual number of molecular biology laboratories in Africa.)

Assuming that each PCR reaction requires approximately 2.5 units (U) of Taq DNA polymerase:

1,000,000 reactions/month × 2.5 U/reaction

= 2,500,000 U of Taq/month

Therefore, the target is approximately 2.5 million units of recombinant Taq DNA polymerase per month.

Gómez Gutiérrez et al. (2002) reported the production of recombinant Taq DNA polymerase using E.coli and obtained approximately 100,000 U of purified Taq DNA polymerase per litre of bacterial culture.

Therefore:

2,500,000 U required ÷ 100,000 U/L

= 25 L of E. coli culture

Thus, approximately 25 L of E.coli culture would theoretically be required to produce the amount of Taq needed for 1 million PCR reactions.

In a real manufacturing process, some product would be lost during cell harvesting, enzyme extraction, purification, quality control, and formulation.

For this back-of-the-envelope estimate, I assume a 2-fold production margin:

25 L × 2

= 50 L

Therefore, I would design the initial manufacturing system around approximately 50 L of E.coli culture capacity per production cycle.

The proposed manufacturing system would use engineered E. coli as the biological manufacturing chassis and an automated bioreactor to control the cultivation process. The bioreactor could automatically regulate parameters such as temperature, pH, dissolved oxygen, agitation, and nutrient feeding.

For this estimate, I assume the following approximate production times:

• E.coli cultivation and induction: approximately 24 hours
• Cell harvesting and processing: approximately 2–4 hours
• Taq polymerase purification: approximately 8–10 hours
• Quality control, formulation, and packaging: approximately 4–8 hours

Using the upper estimates:

24 hours + 4 hours + 10 hours + 8 hours

= 46 hours

Therefore, I estimate that one production cycle would take approximately 38–46 hours, or approximately 2 days.

At the proposed 50-L production scale, the system would therefore be designed to produce enough recombinant Taq DNA polymerase for approximately 1 million PCR reactions in roughly one 2-day production cycle, assuming the published production yield is achieved.

At a larger commercial scale, multiple automated bioreactors could be operated in parallel. This would allow production capacity to be increased without relying on a single very large reactor. Automated downstream purification, quality-control testing, and liquid handling could also be introduced to increase throughput and reduce manual processing.

Therefore, the proposed system would use approximately 50 L of engineered E. coli culture per production cycle and would require approximately 2 days per cycle to manufacture enough recombinant Taq DNA polymerase to support approximately 1 million PCR reactions.

Potential Bottlenecks

The three biggest technical unknowns in this biomanufacturing system are:

1. Stability and consistency of recombinant Taq expression at scale I would need to determine whether engineered E.coli can consistently maintain the recombinant Taq polymerase plasmid and produce the enzyme at the expected level during large-scale fermentation. At the laboratory scale, successful transformation can be confirmed relatively easily, but at larger production volumes, plasmid stability, cell growth, and recombinant protein expression may vary. I would need to experimentally measure plasmid retention and Taq polymerase expression across the production culture and determine whether the system remains stable throughout fermentation.

2. Taq polymerase yield versus metabolic waste and purification efficiency A major unknown is the amount of active Taq polymerase that can be recovered relative to the biomass and metabolic by-products generated by the E.coli culture. I would need to measure the actual enzyme yield (units of active Taq per litre of culture), the amount of biomass and metabolic waste produced, and the losses that occur during cell harvesting and purification. This would help determine whether the process is economically and technically efficient at a larger scale.

3. Alternative microbial chassis for low-cost production Although E.coli is a well-established recombinant protein production host, I would need to investigate whether other microorganisms could produce Taq polymerase more efficiently or at lower cost. Potential alternatives could be compared based on growth rate, protein expression, plasmid stability, culture requirements, downstream processing requirements, and overall production cost. Experimental comparison would be needed to determine whether E.coli is actually the most suitable chassis for affordable, scalable Taq polymerase production.

Reference

Gómez Gutiérrez, J. G., Bermúdez-Humarán, L. G., Tamez Guerra, R., Adame Rodríguez, J. M., & Montes de Oca Luna, R. (2002). Producción y purificación de la Taq DNA polimerasa a partir de E. coli recombinante. Ciencia UANL, 5(3), 316–321.